Tapewire

Nasdaq · USD

DXCM

DEXCOM INC

Export transactions ↓
Tapewire entity
3114
SEC CIK
0001093557
Parsed reports
937

Last 12 months

Inside the activity.

2 purchase rows · 30 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202523
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202601
May 202603
Jun 202605
Jul 202604
Aug 202607
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2020 Filed Mar 14, 2020 01:07 UTC SaleCommon Stock 3,921 $265.43 $1,040,735.35
Disclosure

SEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 3

Murphy Patrick Michael · CIK 0001692785 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,676

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 11, 2020 Filed Mar 14, 2020 01:07 UTC SaleCommon Stock 107 $250.20 $26,771.40
Disclosure

SEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 2

Murphy Patrick Michael · CIK 0001692785 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,597

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $250.09 to $250.72. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 11, 2020 Filed Mar 14, 2020 01:07 UTC SaleCommon Stock 54 $246.06 $13,287.32
Disclosure

SEC source: 0001093557-20-000085 · edgardoc.xml · nonDerivative · entry 1

Murphy Patrick Michael · CIK 0001692785 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,704

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $246.00 to $246.0626. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 3,158 $273.30 $863,096.87
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 10

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,791

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $272.89 to $273.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 600 $272.27 $163,359.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 9

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,949

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $271.85 to $272.59. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 200 $270.51 $54,101.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 8

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,549

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $270.01 to $271.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 200 $269.00 $53,799.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 7

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,749

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $268.99 to $269.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 1,300 $268.07 $348,490.48
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 6

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,949

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $267.745 to $268.545. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 1,500 $267.13 $400,699.35
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 5

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,249

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $266.67 to $267.64. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 100 $264.93 $26,493.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 4

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,749

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 300 $263.15 $78,945.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 3

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,849

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 300 $262.00 $78,600.00
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 2

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,149

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:56 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 227 $261.55 $59,371.01
Disclosure

SEC source: 0001093557-20-000083 · edgardoc.xml · nonDerivative · entry 1

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,449

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $261.00 to $261.80. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 24,715 unvested restricted stock units, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021, and 6,875 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:29 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 439 $261.00 $114,579.00
Disclosure

SEC source: 0001093557-20-000081 · edgardoc.xml · nonDerivative · entry 2

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,395

F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 00:19 UTC
Blackford Quentin S.Chief Operating Officer & CFO
SaleCommon Stock 891 $261.00 $232,551.00
Disclosure

SEC source: 0001093557-20-000077 · edgardoc.xml · nonDerivative · entry 2

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,764

F3 · shares: On December 9, 2019, Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 69,029 unvested restricted stock units, 12,727 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 12,288 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 31,180 of which were granted on September 7, 2017 and shall vest through September 7, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 120 $273.05 $32,766.50
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 11

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,390

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $273.025 to $273.06. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 2,276 $272.51 $620,242.09
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 10

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,510

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $272.00 to $272.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 200 $271.46 $54,292.00
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 9

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,786

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $271.00 to $271.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 250 $269.00 $67,250.00
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 8

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,986

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 1,098 $268.01 $294,277.51
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 7

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,236

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $267.99 to $268.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 1,152 $267.21 $307,821.54
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 6

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,334

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $266.71 to $267.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 150 $264.72 $39,707.51
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 5

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,486

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $264.29 to $264.93. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 250 $263.15 $65,787.50
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 4

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,636

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 250 $262.00 $65,500.00
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 3

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,886

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
SaleCommon Stock 254 $261.63 $66,453.99
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 2

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,136

F3 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $261.00 to $261.80. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 09, 2020 Filed Mar 10, 2020 22:49 UTC SaleCommon Stock 500 $261.00 $130,500.00
Disclosure

SEC source: 0001093557-20-000056 · edgardoc.xml · nonDerivative · entry 2

Murphy Patrick Michael · CIK 0001692785 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,758

F3 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 22:57 UTC
Abbey DonaldEVP Quality and Regulatory Aff
GrantCommon Stock 8,811 $0.00 $8.81
Disclosure

SEC source: 0001093557-20-000058 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,757

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 11, 2020 00:29 UTC
Selvaraj Shelly RamasamySVP Information Technology
GrantCommon Stock 5,483 $0.00 $5.48
Disclosure

SEC source: 0001093557-20-000081 · edgardoc.xml · nonDerivative · entry 1

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,834

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020.

Read SEC document
March 08, 2020 Filed Mar 11, 2020 00:23 UTC
Sylvain Jereme MSVP, Finance & CAO
GrantCommon Stock 5,483 $0.00 $5.48
Disclosure

SEC source: 0001093557-20-000079 · edgardoc.xml · nonDerivative · entry 1

Sylvain Jereme M · CIK 0001681267 · SVP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,030

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 11,247 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 3,216 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 2,548 of which were granted on November 8, 2018 and shall vest through November 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 11, 2020 00:19 UTC
Blackford Quentin S.Chief Operating Officer & CFO
GrantCommon Stock 12,727 $0.00 $12.73
Disclosure

SEC source: 0001093557-20-000077 · edgardoc.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,655

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 69,029 unvested restricted stock units, 12,727 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 12,288 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 31,180 of which were granted on September 7, 2017 and shall vest through September 7, 2021.

Read SEC document
March 08, 2020 Filed Mar 11, 2020 00:04 UTC
Leach Jacob StevenEVP Chief Technology Officer
GrantCommon Stock 11,748 $0.00 $11.75
Disclosure

SEC source: 0001093557-20-000075 · edgardoc.xml · nonDerivative · entry 1

Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,407

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 31,770 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 23:46 UTC GrantCommon Stock 8,811 $0.00 $8.81
Disclosure

SEC source: 0001093557-20-000071 · edgardoc.xml · nonDerivative · entry 1

Balo Andrew K · CIK 0001323190 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,749

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 31,636 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 23:40 UTC
DOUBLEDAY RICHARDEVP Chief Commercial Officer
GrantCommon Stock 11,748 $0.00 $11.75
Disclosure

SEC source: 0001093557-20-000068 · edgardoc.xml · nonDerivative · entry 1

DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,308

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 35,492 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 10,910 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 23:34 UTC
SAYER KEVIN RDirector · President, CEO and Chairman
GrantCommon Stock 25,453 $0.00 $25.45
Disclosure

SEC source: 0001093557-20-000065 · edgardoc.xml · nonDerivative · entry 1

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,390

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 23:26 UTC
Pacelli Steven RobertEVP Strategy and Corporate Dev
GrantCommon Stock 8,811 $0.00 $8.81
Disclosure

SEC source: 0001093557-20-000062 · edgardoc.xml · nonDerivative · entry 1

Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,362

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 31,636 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 23:17 UTC
MOY JEFFREYEVP Operations
GrantCommon Stock 8,811 $0.00 $8.81
Disclosure

SEC source: 0001093557-20-000060 · edgardoc.xml · nonDerivative · entry 1

MOY JEFFREY · CIK 0001446422 · EVP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,219

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 26,651 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 08, 2020 Filed Mar 10, 2020 22:49 UTC GrantCommon Stock 8,811 $0.00 $8.81
Disclosure

SEC source: 0001093557-20-000056 · edgardoc.xml · nonDerivative · entry 1

Murphy Patrick Michael · CIK 0001692785 · *

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,258

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

Read SEC document
March 05, 2020 Filed Mar 9, 2020 21:11 UTC
Pacelli Steven RobertEVP Strategy and Corporate Dev
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 8,927 $0.00 Strike: $9.80 $0.00
Disclosure

SEC source: 0001093557-20-000047 · edgardoc.xml · derivative · entry 2

Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,927 shares

Expires 2020-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2020 Filed Mar 9, 2020 21:11 UTC
Pacelli Steven RobertEVP Strategy and Corporate Dev
Exercise / conversionCommon Stock 8,927 $9.80 $87,484.60
Disclosure

SEC source: 0001093557-20-000047 · edgardoc.xml · nonDerivative · entry 1

Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,551

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 84 $288.26 $24,213.84
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 11

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,147

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 75 $285.48 $21,411.06
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 10

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,231

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $285.445 to $286.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 84 $282.77 $23,752.68
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 9

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,306

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 53 $281.61 $14,925.07
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 8

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,390

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 31 $279.60 $8,667.57
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 7

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,443

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $278.985 to $279.935. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 64 $277.48 $17,758.81
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 6

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,474

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $276.70 to $277.62. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 114 $275.56 $31,413.97
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 5

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,538

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $275.385 to $275.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 155 $274.88 $42,606.93
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 4

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,652

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $274.195 to $275.185. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 81 $272.82 $22,098.42
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,807

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 152 $271.54 $41,273.97
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,888

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $271.37 to $271.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
March 03, 2020 Filed Mar 4, 2020 23:42 UTC SaleCommon Stock 107 $270.63 $28,957.00
Disclosure

SEC source: 0001093557-20-000045 · edgardoc.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 14,040

F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $270.04 to $271.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.